• Cyclosporin A: Optimizing T-cell Inhibition & Mitochondrial

  2026-06-09

  Cyclosporin A, the gold-standard immunosuppressive cyclic undecapeptide, is indispensable for dissecting T-cell activation and mitochondrial function. This article delivers advanced workflow enhancements, troubleshooting strategies, and actionable insights to elevate your immunology and mitochondrial research with APExBIO’s Cyclosporin.

• High-Concentration Lipid Nanoparticles Enhance mRNA Delivery

  2026-06-08

  The referenced study demonstrates that increasing lipid mixture concentrations in lipid nanoparticle (LNP) formulations preserves particle characteristics while significantly boosting in vivo gene expression and storage stability. These findings offer a scalable pathway for improving mRNA-LNP therapeutics and provide actionable insights for optimizing bioluminescent reporter assays and other mRNA applications.

• Magnetic Stimulation and GABAA ε Subunit Modulation in Schiz

  2026-06-08

  This study demonstrates that precise magnetic stimulation of the left prelimbic cortex downregulates the GABAA receptor epsilon subunit, alleviating schizophrenia-like behaviors and synaptic deficits in mice. The findings clarify molecular mechanisms underlying noninvasive brain stimulation and highlight new therapeutic targets for schizophrenia research.

• ARCA Cy5 EGFP mRNA (5-moUTP): Optimizing mRNA Delivery Analy

  2026-06-07

  ARCA Cy5 EGFP mRNA (5-moUTP) empowers researchers to directly visualize and quantify mRNA delivery, localization, and translation in mammalian cells using dual fluorescence. Its immune-evasive modifications and stability enhancements make it a superior tool for troubleshooting and refining mRNA transfection workflows across research and translational pipelines.

• CTP Solution (100 mM): Molecular Basis for Precision RNA Syn

  2026-06-06

  Explore the scientific foundation and advanced use of CTP Solution (100 mM) as a high-fidelity substrate for RNA synthesis, focusing on its essential role in modern mRNA therapeutics. This article delivers unique mechanistic insights and protocol guidance for researchers optimizing in vitro transcription.

• Brassinolide (A3265): Structure, Bioactivity, and Research U

  2026-06-05

  Brassinolide is a key plant sterol and growth regulator with robust, cross-domain research applications. Mechanistically, it induces apoptosis in PC-3 prostate cancer cells and lowers blood glucose in diabetic rat models. Its activity as a plant growth promoter is well-characterized and benchmarked against synthetic analogs.

• CD28–ARS2 Axis Drives PKM2 Splicing and CD8+ T Cell Antitumo

  2026-06-05

  This study uncovers a novel mechanism by which the CD28–ARS2 signaling axis orchestrates alternative splicing of pyruvate kinase (PKM), promoting PKM2 expression and enhancing the metabolic flexibility and effector function of CD8+ T cells. These findings have significant implications for immunometabolic research and the development of strategies targeting T cell-mediated antitumor responses.

• Sarmentosin Drives Autophagy-Dependent Apoptosis in HCC via

  2026-06-04

  This study demonstrates that sarmentosin, a natural product from Sedum sarmentosum, induces autophagy-dependent apoptosis in hepatocellular carcinoma (HCC) by activating Nrf2 and inhibiting mTOR signaling. These mechanistic insights highlight Nrf2 as a promising therapeutic target in HCC and support further exploration of autophagy modulation strategies for overcoming apoptosis resistance in liver cancer.

• Tropifexor (LJN452): Applied FXR Modulation for Barrier Rese

  2026-06-04

  Tropifexor (LJN452) is redefining intestinal epithelial barrier function research by enabling highly selective, reproducible modulation of the FXR signaling pathway. This article delivers concrete workflow guidance, troubleshooting, and advanced protocol tips for leveraging Tropifexor in metabolic and liver disease models, with insights based on recent neonatal piglet and organoid studies.

• SLC25A1 Drives Cisplatin Resistance via H3K27ac-Mediated Sen

  2026-06-03

  Li et al. (2026) demonstrate that SLC25A1 upregulation in head and neck squamous cell carcinoma (HNSCC) enhances cisplatin resistance by promoting cellular senescence through H3K27 acetylation. This mechanistic insight positions SLC25A1 as both a predictive biomarker and a potential therapeutic target for overcoming chemoresistance in HNSCC.

• PF-562271 HCl: Optimizing FAK/Pyk2 Inhibition in Cancer Rese

  2026-06-03

  PF-562271 HCl stands out for its superb selectivity and potency as a FAK/Pyk2 inhibitor, enabling researchers to precisely dissect tumor growth and microenvironmental signaling. This article delivers actionable workflows, evidence-driven troubleshooting, and deep domain integration for advanced cancer research.

• Paroxetine Mesylate: Beyond SSRI – Novel Oncology and Kinase

  2026-06-02

  Explore Paroxetine Mesylate as a selective serotonin reuptake inhibitor with unique multi-kinase and anticancer properties. This article reveals underappreciated assay design considerations and mechanistic advances, setting it apart from conventional overviews.

• RapaLink-1: Third-Generation mTOR Inhibitor for Dormancy and

  2026-06-02

  RapaLink-1 stands out as a third-generation mTOR inhibitor, uniquely enabling both robust tumor suppression and noninvasive induction of embryonic dormancy. This guide details actionable protocols, troubleshooting insights, and comparative advantages for researchers aiming to overcome resistance and achieve precise control of the PIK3CA–AKT–mTOR pathway.

• PF-04971729 (Ertugliflozin): Translational Leverage in Metab

  2026-06-01

  This thought-leadership article for translational researchers offers a mechanistic and strategic exploration of Ertugliflozin (PF-04971729), highlighting its unique selectivity, preclinical and clinical data, and actionable guidance to bridge renal, metabolic, and cardiovascular axes. Integrating evidence from pivotal studies and the latest mechanistic insights, the discussion provides a roadmap for leveraging APExBIO’s Ertugliflozin in advanced diabetes, cardioprotection, and inflammation models.

• Polyethylenimine Linear (PEI), MW 40,000: Optimizing Transfe

  2026-06-01

  Explore how Polyethylenimine Linear (PEI), MW 40,000 elevates DNA transfection efficiency in modern molecular biology. This article uniquely connects mechanistic insight with experimental protocol optimization, informed by new comparative findings.

446 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page